Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.
A preview of the earnings announcements for the day, including HP, with Jayson Noland, Robert W. Baird sr. analyst and Mark Stahlman, Signal Lake Ventures technology strategist.